ADA, A. O. Et Al. 2009. The role of CYP1A1 (Ile462Val) and CYP1B1 (Asn453Ser) polymorphisms in response to chemotherapy and survival in lung cancer patients. 46th Congress of the European-Societies-of-Toxicology , (Dresden, Germany).

ADA, A. O., Bilgen, S., KUNAK, C. S., Hancer, F., SÜZEN, H. S., Alpar, S., ... Gulhan, M.(2009). The role of CYP1A1 (Ile462Val) and CYP1B1 (Asn453Ser) polymorphisms in response to chemotherapy and survival in lung cancer patients . 46th Congress of the European-Societies-of-Toxicology, Dresden, Germany

ADA, AHMET Et Al. "The role of CYP1A1 (Ile462Val) and CYP1B1 (Asn453Ser) polymorphisms in response to chemotherapy and survival in lung cancer patients," 46th Congress of the European-Societies-of-Toxicology, Dresden, Germany, 2009

ADA, AHMET O. Et Al. "The role of CYP1A1 (Ile462Val) and CYP1B1 (Asn453Ser) polymorphisms in response to chemotherapy and survival in lung cancer patients." 46th Congress of the European-Societies-of-Toxicology , Dresden, Germany, 2009

ADA, A. O. Et Al. (2009) . "The role of CYP1A1 (Ile462Val) and CYP1B1 (Asn453Ser) polymorphisms in response to chemotherapy and survival in lung cancer patients." 46th Congress of the European-Societies-of-Toxicology , Dresden, Germany.

@conferencepaper{conferencepaper, author={AHMET OĞUZ ADA Et Al. }, title={The role of CYP1A1 (Ile462Val) and CYP1B1 (Asn453Ser) polymorphisms in response to chemotherapy and survival in lung cancer patients}, congress name={46th Congress of the European-Societies-of-Toxicology}, city={Dresden}, country={Germany}, year={2009}}